WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009132660) AGENTS BINDING TO MEGALIN OR SEX HORMONE BINDING GLOBULIN AND COMPOSITIONS THEROF FOR TREATMENT OF STEROID DEPENDENT CANCERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/132660    International Application No.:    PCT/DK2009/050104
Publication Date: 05.11.2009 International Filing Date: 30.04.2009
IPC:
A61K 39/395 (2006.01), A61P 35/00 (2006.01)
Applicants: RECEPTICON APS [DK/DK]; Fruebjergvej 3 P.O. Box 35 DK-1869 Copenhagen Ø (DK) (For All Designated States Except US).
PEDERSEN, Anders Hjelholt [DK/DK]; (DK) (For US Only).
HEJNAES, Kim [DK/DK]; (DK) (For US Only)
Inventors: PEDERSEN, Anders Hjelholt; (DK).
HEJNAES, Kim; (DK)
Agent: HØIBERG A/S; St. Kongensgade 59A DK-1264 Copenhagen K (DK)
Priority Data:
PA 2008 00609 30.04.2008 DK
Title (EN) AGENTS BINDING TO MEGALIN OR SEX HORMONE BINDING GLOBULIN AND COMPOSITIONS THEROF FOR TREATMENT OF STEROID DEPENDENT CANCERS
(FR) AGENTS SE LIANT À LA MÉGALINE OU À UNE GLOBULINE DE LIAISON À UNE HORMONE SEXUELLE ET LEURS COMPOSITIONS POUR LE TRAITEMENT DE CANCERS DÉPENDANTS DES HORMONES STÉROÏDES
Abstract: front page image
(EN)The present invention provides agents and compositions targeting megalin and/or sex hormone binding globulin (SHBG) for blocking steroid hormone transport into cells, and thereby provide a new method for treatment of steroid dependent cancers, including prostate cancer and breast cancer, such as estrogen receptor positive (ER+) breast cancer.
(FR)La présente invention porte sur des agents et sur des compositions ciblant la mégaline et/ou la globuline de liaison à une hormone sexuelle (SHBG) pour bloquer un transport d'hormone stéroïde dans des cellules, et fournir ainsi un nouveau procédé pour le traitement de cancers dépendants des hormones stéroïdes, comprenant le cancer de la prostate et le cancer du sein, et tel qu'un cancer du sein positif au récepteur de l'œstrogène (ER+).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)